Evidence map›Paper›PMID 29705281›Full record

ArticleAcademic radiology2019

A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Sonia Gaur, Stephanie Harmon, Rajan T Gupta, Daniel J Margolis, Nathan Lay, Sherif Mehralivand, Maria J Merino, Bradford J Wood, Peter A Pinto, Joanna H Shih and 2 more

Abstract read
In one paragraph

Article in Academic radiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Rapid perceptual processing in two- and three-dimensional prostate images.Journal of medical imaging (Bellingham, Wash.) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Sonia GaurMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD 20814.
Stephanie HarmonClinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., National Cancer Institute, Frederick, Maryland.
Rajan T GuptaDuke University Medical Center, Duke Cancer Institute, Durham, North Carolina.
Daniel J MargolisWeill Cornell Imaging, New York-Presbytarian Hospital, New York, New York.
Nathan LayComputer-Aided Diagnosis Laboratory, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Sherif MehralivandUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Maria J MerinoDepartment of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Bradford J WoodCenter for Interventional Oncology, Clinical Center, National Institutes of Health, Bethesda, Maryland.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Joanna H ShihBiometric Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Peter L ChoykeMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD 20814.
Baris TurkbeyMolecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD 20814. Electronic address: turkbeyi@mail.nih.gov.
National Institutes of Health · USNational Cancer Institute · USNational Institutes of Health Clinical Center · USDuke Medical Center · USLeidos (United States) · USPresbyterian Hospital · US

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
CCR NIH HHS HHSN261200800001CIntramural NIH HHS Z99 CA999999NCI NIH HHS HHSN261200800001ENULL Z99 CA999999
6 · The paper itself

Abstract

RATIONALE AND

objectivesTo determine independent contribution of each prostate multiparametric magnetic resonance imaging (mpMRI) sequence to cancer detection when read in isolation. MATERIALS AND

methodsProstate mpMRI at 3-Tesla with endorectal coil from 45 patients (n = 30 prostatectomy cases, n = 15 controls with negative magnetic resonance imaging [MRI] or biopsy) were retrospectively interpreted. Sequences (T2-weighted [T2W] MRI, diffusion-weighted imaging [DWI], and dynamic contrast-enhanced [DCE] MRI; N = 135) were separately distributed to three radiologists at different institutions. Readers evaluated each sequence blinded to other mpMRI sequences. Findings were correlated to whole-mount pathology. Cancer detection sensitivity, positive predictive value for whole prostate (WP), transition zone, and peripheral zone were evaluated per sequence by reader, with reader concordance measured by index of specific agreement. Cancer detection rates (CDRs) were calculated for combinations of independently read sequences.

results44 patients were evaluable (cases median prostate-specific antigen 6.83 [ range 1.95-51.13] ng/mL, age 62 [45-71] years; controls prostate-specific antigen 6.85 [2.4-10.87] ng/mL, age 65.5 [47-71] years). Readers had highest sensitivity on DWI (59%) vs T2W MRI (48%) and DCE (23%) in WP. DWI-only positivity (DWI+/T2W-/DCE-) achieved highest CDR in WP (38%), compared to T2W-only (CDR 24%) and DCE-only (CDR 8%). DWI+/T2W+/DCE- achieved CDR 80%, an added benefit of 56.4% from T2W-only and of 42% from DWI-only (P < .0001). All three sequences interpreted independently positive gave highest CDR of 90%. Reader agreement was moderate (index of specific agreement: T2W = 54%, DWI = 58%, DCE = 33%).

conclusionsWhen prostate mpMRI sequences are interpreted independently by multiple observers, DWI achieves highest sensitivity and CDR in transition zone and peripheral zone. T2W and DCE MRI both add value to detection; mpMRI achieves highest detection sensitivity when all three mpMRI sequences are positive.

Indexed as

Multiparametric Magnetic Resonance ImagingAgedDiffusion Magnetic Resonance ImagingHumansMaleMiddle AgedObserver VariationPredictive Value of TestsProstatectomyProstate-Specific AntigenProstatic NeoplasmsRetrospective StudiesProstate-Specific AntigenMRIMultiparametricPI-RADSv2prostatesequence

Identifiers

PMID29705281
PMCPMC6202287
OpenAlexW2800197636

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.